DXP合成酶的双基质模拟抑制剂显示了物种特异性
Stephanie Henriquez1,2, Charles R Nosal1,2, Joseph R Knoff1
1Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, United States.
Biochemistry
|January 7, 2025
概括
1 - 脱氧-d - 硫 5-酸盐合成酶 (DXPS) 是细菌中的一个关键酶. 研究人员发现,对大肠杆菌DXPS有效的抑制剂对Pseudomonas aeruginosaDXPS的有效性较低,这揭示了针对药物开发的物种特异性差异.
科学领域:
- 生物化学和酶学 生物化学和酶学
- 微生物的新陈代谢
- 药物的发现和开发.
背景情况:
- 1-deoxy-d-xylulose 5-phosphate synthase (DXPS) 是一种依赖于硫胺二酸盐 (ThDP) 的酶,对细菌病原体中异类和维生素生物合成至关重要.
- DXPS具有宽松的基质特异性和封闭机制,使其能够在感染期间适应各种基质和代谢需求.
- DXPS是双基质类似物对时间依赖性抑制的目标,为抗菌药物开发提供了潜力.
研究的目的:
- 调查已知的双基质模拟抑制剂对来自*Escherichia coli* (*Ec*DXPS) 和*Pseudomonas aeruginosa* (*Pa*DXPS) 的DXPS的特定物种疗效.
- 为了阐明 *Ec*DXPS 和 *Pa*DXPS 之间的联结体受阻的机制差异.
- 评估开发针对细菌病原体DXPS的特定物种抑制剂的潜力.
主要方法:
- 对已知双基质模拟抑制剂的评估,包括d-PheTrAP和BAP支架,与纯化的*Ec*DXPS和*Pa*DXPS对比.
- 对抑制剂强度和时间依赖的抑制动力学的比较分析.
- 关键受体部位残留物 (如*Ec*R99和*Pa*R106) 的位点定向突变发生,以评估它们在索-ThDP附加物 (PLThDP) 的抑制剂结合和稳定中的作用.
主要成果:
- 与*Ec*DXPS相比,双基质模拟抑制剂对*Pa*DXPS的有效性明显较低.
- 在*Ec*DXPS中稳定PLThDP adduct的关键受体位残留物对*Pa*DXPS的稳定不那么关键.
- 虽然氨酸残留物 (*Ec*R99和*Pa*R106) 在稳定PLThDP附加物中很常见,但*Pa*R106与*Ec*R99.9不同,没有控制缓慢发作的抑制.
结论:
- 在*E. coli*和*P. aeruginosa*之间,在DXPS的联体门抑制中存在机制上的差异.
- 双基质类似物对DXPS的特定物种向是可行的.
- 这些发现强调了考虑同类特异机制设计针对细菌DXPS的窄谱抑制剂的重要性.
相关概念视频
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
ATP Synthase: Mechanism
13.9K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
13.9K
Enzyme Inhibition
77.8K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
77.8K
The Electron Transport Chain
16.0K
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
16.0K
Eukaryotic Transcription Inhibitors
9.8K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.8K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.6K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.6K


